Department of Neurosurgery, Brigham and Women's Hospital, and Harvard Medical School, 221 Longwood Avenue, LMRC-322, Boston, Massachusetts 02115, United States.
Anal Chem. 2012 Nov 20;84(22):9889-98. doi: 10.1021/ac302278u. Epub 2012 Nov 6.
Liquid chromatography (LC) separation combined with electrochemical coulometric array detection (EC) is a sensitive, reproducible, and robust technique that can detect hundreds of redox-active metabolites down to the level of femtograms on column, making it ideal for metabolomics profiling. EC detection cannot, however, structurally characterize unknown metabolites that comprise these profiles. Several aspects of LC-EC methods prevent a direct transfer to other structurally informative analytical methods, such as LC-MS and NMR. These include system limits of detection, buffer requirements, and detection mechanisms. To address these limitations, we developed a workflow based on the concentration of plasma, metabolite extraction, and offline LC-UV fractionation. Pooled human plasma was used to provide sufficient material necessary for multiple sample concentrations and platform analyses. Offline parallel LC-EC and LC-MS methods were established that correlated standard metabolites between the LC-EC profiling method and the mass spectrometer. Peak retention times (RT) from the LC-MS and LC-EC system were linearly related (r(2) = 0.99); thus, LC-MS RTs could be directly predicted from the LC-EC signals. Subsequent offline microcoil-NMR analysis of these collected fractions was used to confirm LC-MS characterizations by providing complementary, structural data. This work provides a validated workflow that is transferrable across multiple platforms and provides the unambiguous structural identifications necessary to move primary mathematically driven LC-EC biomarker discovery into biological and clinical utility.
液相色谱(LC)分离与电化学库仑阵列检测(EC)相结合,是一种灵敏、重现性好且稳健的技术,可在柱上检测到数百种具有氧化还原活性的代谢物,达到飞克级水平,非常适合代谢组学分析。然而,EC 检测无法对构成这些图谱的未知代谢物进行结构特征分析。LC-EC 方法的几个方面阻止了其直接转移到其他具有结构信息的分析方法,如 LC-MS 和 NMR。这些方面包括系统检测限、缓冲液要求和检测机制。为了解决这些限制,我们开发了一种基于血浆浓度、代谢物提取和离线 LC-UV 分级的工作流程。使用人血浆汇集物提供足够的材料,以进行多个样品浓度和平台分析。建立了离线平行 LC-EC 和 LC-MS 方法,将标准代谢物的峰保留时间(RT)相关联(r²=0.99);因此,可以直接从 LC-EC 信号预测 LC-MS RT。随后对这些收集的级分进行离线微线圈 NMR 分析,通过提供互补的结构数据来确认 LC-MS 特征。这项工作提供了一个经过验证的工作流程,可在多个平台上进行转移,并提供了将主要基于数学的 LC-EC 生物标志物发现转化为生物学和临床应用所需的明确结构鉴定。